CEO of Health Catalyst Inc (30-Year Financial, Insider Trades) Daniel D. Burton (insider trades) sold 140,908 shares of HCAT on 06/26/2020 at an average price of $30.9 a share. The total sale was $4.4 million.
Health Catalyst Inc has a market cap of $1.11 billion; its shares were traded at around $29.17 with and P/S ratio of 5.98. GuruFocus has detected 1 severe warning sign with Health Catalyst Inc. .
CEO Recent Trades:
- CEO Daniel D. Burton sold 140,908 shares of HCAT stock on 06/26/2020 at the average price of $30.9. The price of the stock has decreased by 5.6% since.
CFO Recent Trades:
- CFO James Patrick Jr. Nelli sold 80,000 shares of HCAT stock on 06/22/2020 at the average price of $32.35. The price of the stock has decreased by 9.83% since.
Directors and Officers Recent Trades:
- General Counsel Daniel H. Orenstein sold 10,000 shares of HCAT stock on 06/19/2020 at the average price of $32. The price of the stock has decreased by 8.84% since.
- Chief People Officer Linda Llewelyn sold 1,121 shares of HCAT stock on 06/08/2020 at the average price of $30. The price of the stock has decreased by 2.77% since.
- Chief Technology Officer Dale Sanders sold 27,500 shares of HCAT stock on 06/01/2020 at the average price of $26.97. The price of the stock has increased by 8.16% since.
- Chief People Officer Linda Llewelyn sold 1,121 shares of HCAT stock on 06/01/2020 at the average price of $26.97. The price of the stock has increased by 8.16% since.
- COO Paul Horstmeier sold 10,750 shares of HCAT stock on 06/01/2020 at the average price of $26.97. The price of the stock has increased by 8.16% since.
For the complete insider trading history of HCAT, click here
.
